Jack Lee
In vivo Operations Manager at Pharmaron- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
David Canton
Jack joined ONCS in September 2016 and immediately became an integral part of my team. He is a very thoughtful and careful scientist, with exceptional technical skills and strong troubleshooting abilities. He took the lead in designing and running cell-based assays, ELISAs, IBs and FACS, training junior scientists and managing the lab. He was always keen to learn new things and quickly became adept at various molecular biology techniques. Jack's tenure at Oncosec was brief, though not through any fault of his own nor by my choice (he was caught in a structural reorganization). All of his work on my team was exceptional and he was very well-liked and respected by his colleagues. I highly recommend Jack for employment. He is a very strong candidate and an asset to any team. Please contact me for a reference or additional information. David Canton
David Canton
Jack joined ONCS in September 2016 and immediately became an integral part of my team. He is a very thoughtful and careful scientist, with exceptional technical skills and strong troubleshooting abilities. He took the lead in designing and running cell-based assays, ELISAs, IBs and FACS, training junior scientists and managing the lab. He was always keen to learn new things and quickly became adept at various molecular biology techniques. Jack's tenure at Oncosec was brief, though not through any fault of his own nor by my choice (he was caught in a structural reorganization). All of his work on my team was exceptional and he was very well-liked and respected by his colleagues. I highly recommend Jack for employment. He is a very strong candidate and an asset to any team. Please contact me for a reference or additional information. David Canton
David Canton
Jack joined ONCS in September 2016 and immediately became an integral part of my team. He is a very thoughtful and careful scientist, with exceptional technical skills and strong troubleshooting abilities. He took the lead in designing and running cell-based assays, ELISAs, IBs and FACS, training junior scientists and managing the lab. He was always keen to learn new things and quickly became adept at various molecular biology techniques. Jack's tenure at Oncosec was brief, though not through any fault of his own nor by my choice (he was caught in a structural reorganization). All of his work on my team was exceptional and he was very well-liked and respected by his colleagues. I highly recommend Jack for employment. He is a very strong candidate and an asset to any team. Please contact me for a reference or additional information. David Canton
David Canton
Jack joined ONCS in September 2016 and immediately became an integral part of my team. He is a very thoughtful and careful scientist, with exceptional technical skills and strong troubleshooting abilities. He took the lead in designing and running cell-based assays, ELISAs, IBs and FACS, training junior scientists and managing the lab. He was always keen to learn new things and quickly became adept at various molecular biology techniques. Jack's tenure at Oncosec was brief, though not through any fault of his own nor by my choice (he was caught in a structural reorganization). All of his work on my team was exceptional and he was very well-liked and respected by his colleagues. I highly recommend Jack for employment. He is a very strong candidate and an asset to any team. Please contact me for a reference or additional information. David Canton
Credentials
-
Project Management Boot Camp
UC San Diego Extended StudiesAug, 2022- Nov, 2024 -
Certified Associate in Project Management (CAPM)
Project Management InstituteJun, 2021- Nov, 2024 -
Illustrator CC 2019 Essential Training
LinkedInMar, 2021- Nov, 2024 -
PMP Certification Course
SimplilearnSep, 2019- Nov, 2024
Experience
-
Pharmaron
-
China
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
In vivo Operations Manager
-
Dec 2022 - Present
We deliver a comprehensive range of non-clinical research services for all biomedical products with the highest data quality and integrity, focused on timely communication and exemplary customer service, to better predict human outcomes. We deliver a comprehensive range of non-clinical research services for all biomedical products with the highest data quality and integrity, focused on timely communication and exemplary customer service, to better predict human outcomes.
-
-
-
OncoSec
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Associate Scientist II
-
Aug 2022 - Oct 2022
-
-
-
Onchilles Pharma
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Project Manager
-
Mar 2022 - Aug 2022
-
-
-
OncoSec
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Associate Scientist II
-
Aug 2018 - Mar 2022
Member of the Research and Development team tasked with coordinating all phases of research & development projects in expanding and emboldening company’s immunotherapy pipelines. Providing project management support encompassing management of R&D project timelines, of team’s operational and logistical plans, and of execution on strategies and critical paths as they relate to time-sensitive milestones. In addition, implementing cross-functional support for the Clinical Science group with assay development, and data management; also providing technical expertise and mentorship to junior research members.
-
-
-
IGNYTA, Inc.
-
San Diego, California
-
Associate Scientist
-
Feb 2017 - Jun 2018
Member of an interdepartmental team tasked with elucidating the mechanism of action of RXDX-106 as a tumor suppressor with immuno-oncological potential, leading to a successful IND filing with the FDA, and the start of a Phase I clinical trial. Member of an interdepartmental team tasked with elucidating the mechanism of action of RXDX-106 as a tumor suppressor with immuno-oncological potential, leading to a successful IND filing with the FDA, and the start of a Phase I clinical trial.
-
-
-
OncoSec
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Research Associate
-
Sep 2016 - Dec 2016
Member of the Discovery Research department, responsible for developing in vitro assays, generating and analyzing data for the Molecular Biology group, tasked with improving clinical immuno-oncology strategies as well as designing new therapeutic candidates. Member of the Discovery Research department, responsible for developing in vitro assays, generating and analyzing data for the Molecular Biology group, tasked with improving clinical immuno-oncology strategies as well as designing new therapeutic candidates.
-
-
-
Applied Proteomics, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Research Associate
-
Nov 2013 - Sep 2016
Member and team leader of multiple cross-functional projects in developing a blood-based colorectal cancer laboratory developed test. Also, managed technical troubleshooting and support for clinical operations. Member and team leader of multiple cross-functional projects in developing a blood-based colorectal cancer laboratory developed test. Also, managed technical troubleshooting and support for clinical operations.
-
-
-
Brigham and Women's Hospital
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Lab Manager and Senior Research Associate
-
Feb 2005 - Aug 2013
Lead personnel of laboratory’s expertise in shear-dependent cellular trafficking, transendothelial migration (TEM) and other in vitro shear-based assays. I also managed the overall, day-to-day laboratory operations and fostered communications within the laboratory group but also with outside collaborators. • Pioneered adaptations to the Transendothelial Migration Chamber (TEMC) to accommodate rapid modulations of chemokine gradients across endothelial monolayers, mimicking the physiological environment. • Led a study to elucidate T-cell TEM and retrograde TEM in response to rapid changes in chemokine gradients. • Oversaw a collaborative project in revealing CD4 T-cell trafficking and accumulation in response to soluble HIV-1 gp120. • Designed and spearheaded experiments to observe granulocyte adhesion deficiencies in CDG2c/LAD2 patients. • Supported other projects studying trafficking of lymphoma cells, modified mesenchymal stem cells and hematopoietic progenitor cells. • Supervised the fusion, screening and maintenance of hybridoma cell lines, producing monoclonal antibodies specific to a glycoform of CD44, Hematopoietic Cell E-/L-selectin Ligand (HCELL). • Developed protocols for purifying monoclonal antibodies from hybridoma cell culture supernatants. • Contributed to the studies of ex vivo glycosylation of cell surface proteins to enhance trafficking of mesenchymal stem cells. • Communicated with international laboratories to negotiate custom production and shipment of reagents needed for studies. • Presented results, conclusions and discovery at weekly group meetings, and often at department meetings. • Managed the use and maintenance of laboratory’s flow cytometer (FC500MPL), cell culture facilities, and equipment for shear-based assays. • Responsible for writing, submitting, and updating laboratory’s IACUC animal protocols and IRB protocols. • Occasionally presided over group meetings, communicating timelines, progress updates and milestones.
-
-
-
Oregon Health & Science University
-
Hospitals and Health Care
-
700 & Above Employee
-
Graduate Research Assistant
-
Sep 2002 - Feb 2005
• Analyzed the protein and mRNA expressions of NOD2/CARD15, a pathogen recognition receptor (PRR), in various tissue-specific endothelial cells in studying the autoinflammatory disorder, Blau syndrome. • Awarded sponsorship through the university’s Ophthalmology Training Grant. • Analyzed the protein and mRNA expressions of NOD2/CARD15, a pathogen recognition receptor (PRR), in various tissue-specific endothelial cells in studying the autoinflammatory disorder, Blau syndrome. • Awarded sponsorship through the university’s Ophthalmology Training Grant.
-
-
-
Brigham and Women's Hospital
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Technical Research Assistant
-
Mar 1999 - Aug 2002
• Assisted in identifying and biochemically characterizing a novel cell surface homing glycoprotein, HCELL, expressed on hematopoietic stem cells and leukemic blasts. • Facilitated the development of a flow-based assay, the blot-rolling assay, used for the identification of adhesion molecules capable of selectin-mediated binding. • Managed day-to-day operations of the laboratory, including ordering supplies and maintaining equipment. • Responsible for mentoring and managing summer students every year.
-
-
Education
-
Cornell University
Bachelor of Arts (BA), Biochemistry -
Oregon Health and Science University
Program of Molecular and Cellular Biosciences - Cell and Developmental Biology